CAD 0.09
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 15.61 Million CAD | 21.6% |
2022 | 12.84 Million CAD | 12.05% |
2021 | 11.46 Million CAD | 26.13% |
2020 | 9.08 Million CAD | 262.6% |
2019 | 2.5 Million CAD | 7703.12% |
2018 | 32.12 Thousand CAD | 124.54% |
2017 | 14.3 Thousand CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 15.9 Million CAD | 1.83% |
2024 Q3 | 15.05 Million CAD | -1.05% |
2024 Q2 | 15.21 Million CAD | -4.34% |
2023 Q2 | 14.62 Million CAD | 12.37% |
2023 Q1 | 13.01 Million CAD | 1.33% |
2023 FY | 15.61 Million CAD | 21.6% |
2023 Q4 | 15.61 Million CAD | 3.33% |
2023 Q3 | 15.11 Million CAD | 3.35% |
2022 Q4 | 12.84 Million CAD | 8.73% |
2022 Q1 | 11.46 Million CAD | 0.05% |
2022 Q3 | 11.81 Million CAD | -0.19% |
2022 FY | 12.84 Million CAD | 12.05% |
2022 Q2 | 11.83 Million CAD | 3.21% |
2021 Q3 | 9.86 Million CAD | 5.68% |
2021 Q2 | 9.33 Million CAD | 9.4% |
2021 Q1 | 8.53 Million CAD | -6.1% |
2021 Q4 | 11.46 Million CAD | 16.19% |
2021 FY | 11.46 Million CAD | 26.13% |
2020 Q1 | 6.93 Million CAD | 176.51% |
2020 FY | 9.08 Million CAD | 262.6% |
2020 Q4 | 9.08 Million CAD | 0.56% |
2020 Q3 | 9.03 Million CAD | 20.34% |
2020 Q2 | 7.51 Million CAD | 8.37% |
2019 Q1 | 8520.00 CAD | -14.29% |
2019 Q3 | 1.2 Million CAD | 246.39% |
2019 Q4 | 2.5 Million CAD | 108.64% |
2019 FY | 2.5 Million CAD | 7703.12% |
2019 Q2 | 346.8 Thousand CAD | 3970.43% |
2018 Q4 | 9940.00 CAD | 74.48% |
2018 FY | 32.12 Thousand CAD | 124.54% |
2018 Q3 | 5697.00 CAD | -60.17% |
2018 Q2 | 14.3 Thousand CAD | 4441.27% |
2018 Q1 | 315.00 CAD | -94.84% |
2017 Q4 | 6110.00 CAD | 214.14% |
2017 Q3 | 1945.00 CAD | 0.0% |
2017 FY | 14.3 Thousand CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -190.31% |
Decibel Cannabis Company Inc. | 96.79 Million CAD | 83.863% |
Delivra Health Brands Inc. | 4.85 Million CAD | -221.509% |
Entourage Health Corp. | 178.68 Million CAD | 91.259% |
Lifeist Wellness Inc. | 9.94 Million CAD | -57.121% |
Cannara Biotech Inc. | 61.77 Million CAD | 74.718% |
Medicure Inc. | 8.16 Million CAD | -91.338% |
PharmaCielo Ltd. | 23.96 Million CAD | 34.837% |
Rubicon Organics Inc. | 16.99 Million CAD | 8.106% |
BioSyent Inc. | 6.76 Million CAD | -130.735% |
Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -2045.814% |